NEWS

22/11/24

Newsletter Cerba November 22nd - Tests : new deadlines

30/10/24

Our Customer Service will be closed the 1st and the 11th of November

21/10/24

Newsletter Cerba October 18th - Tests : new deadlines

11/10/24

Newsletter Cerba October 11th - Tests : new deadlines

16/09/24

Newsletter Cerba September 6th - Tests : new deadlines

21/08/24

Newsletter Cerba August 21st - Tests : new deadlines

13/08/24

Newsletter Cerba August 13th - Tests : new turnaround times and public holidays

12/08/24

Newsletter Cerba July 26th - Tests : new deadlines

01/08/24

Newsletter Cerba July 26th - Tests : new deadlines

23/07/24

Newsletter Cerba July 19th - Tests : new turnaround times

15/07/24

Newsletter Cerba July 12th - Tests new delivery schedule

09/07/24

SCREENING FOR FETAL TRISOMY 21 : SERUM MARKERS CHANGE IN PREANALYTICAL CONDITIONS

09/07/24

Newsletter Cerba July 5th - Tests : New delivery schedule and evolutions

24/06/24

New delais and evolutions

17/06/24

New delais and evolutions

17/06/24

New delais and evolutions

11/06/24

Blood serotonins: 2 frozen tubes

30/05/24

23rd of May 2024 Cerba Newsletter

22/05/24

2024 Cerba Newsletter

22/05/24

2024 Cerba Newsletter

29/04/24

The Cerba Newsletter is Evolving in 2024

29/04/24

MOVES IN PROGRESS AND DELAYS

18/04/24

MOVES IN PROGRESS AND DELAYS

21/03/24

Delays and return to normal

12/03/24

The diagnosis of GLUT1 deficiency syndrome

08/03/24

Test : Delay and return to normal

06/03/24

Delay and return to normal

26/02/24

General Information - Stages of the Move

20/02/24

Moving and new deadlines

20/02/24

Moving and new deadlines

09/02/24

Test : Delay and return to normal

23/01/24

An environmentally-friendly site

19/01/24

Predictix® : Next-generation test for prescribing antidepressants

17/01/24

Dosage of 2nd generation antidepressants: a new exam

21/12/23

THE NEW FREPILLON SITE WILL HOUSE 3 ENTITIES

18/12/23

MAY BANK HOLIDAYS: SAMPLING AND OPENING HOURS

15/12/23

Prenatal: fetal sex determination (circulating DNA)

11/12/23

A NEW CHAPTER BEGINS FOR THE CERBA LABORATORY

09/11/23

FOR SOME EXAMINATIONS : NO SAMPLES FROM 9 NOVEMBER (BANK HOLIDAY IN FRANCE : NOVEMBER 11)

20/07/23

Endocrine disruptors, New information on treatment in 2023

04/07/23

21/06/23

ALDOLASE reagent shortage

16/06/23

URINARY METANEPHRINES TEMPORARY EXTENSION OF DELIVERY TIME

26/05/23

Important notice : medium transport for NIPT

10/05/23

Anti-Platelet AC test - Stop

17/04/23

New Site Cerba Oncology

13/04/23

B6 VITAMIN : TECHNICAL CHANGE

12/04/23

NEW TEST : OPTICAL GENOME MAPPING

28/03/23

Midwives Days 2023

20/03/23

Next Cerba Live Session on Thursday 23 March: Analysis of human genomes by optical mapping

13/02/23

Lymphocytes T (T3/T4/T8) reagents

10/10/22

The Customer Relation Desk : Autumn opening hours

30/06/22

Customer service : summer holidays opening hours

20/05/22

Customer service : closed the 26th of May

18/03/22

NIPD, free circulating DNA tests - supplies back in stock

26/01/22

05/07/21

IT Security Incident

11/05/21

New information on Myelogram bone marrow sampling

16/12/20

New: Cerba laboratory now proposes a range of tests for the diagnosis of lysosomal storage diseases.

28/10/20

Dépistage de la pré-éclampsie : de la clinique au laboratoire

22/06/20

New: recombinant peach allergen, rPru p 7 is now available

15/04/20

Change of technique and sample nature for Aldosterone measurement

27/11/19

Attention: new sampling recommendations and pre-analytical conditions for the total IgE in tears

17/09/19

Arrêt du test de l’hydroxyproline urinaire

11/01/19

Laboratoire CERBA enters into licensing agreement with IntegraGen for the commercialization of miR-31-3p tumor expression test in France, Benelux, Middle East and Africa

11/01/19

Laboratoire CERBA and PATHOQUEST announce partnership making the iDTECT™ BLOOD test available for clinical use in the precision diagnosis of infectious diseases

11/01/19

METAglut1, A NEW DIAGNOSTIC TEST FOR THE GLUT1 DEFICIENCY SYNDROME

11/01/19

Cerba HealthCare announces the launch of its endowment funds: « Institut Cerba »

11/01/19

Licensing agreement between Cerba and IntegraGen for the commercialization...

11/01/19

New blood test to diagnose cancers due to HPV.

Lymphocytes T (T3/T4/T8) reagents

Lymphocytes T (T3/T4/T8) reagents

Dear Partners,

Due to a reagent worldwide shortage for the LYMPHOCYTES T (T3/T4/T8), CERBA, its biologists and technicians made every effort to provide a temporary change of technique.
This change only generates an increase of results delivery timeline of 48-hours.

We remain at our all disposal if you have any questions.

Best regards,
The International Commercial Department